A recent publication showed that MPS II mice treated with a genetically engineered fusion protein consisting of a fused IDS molecule to an anti–human TfR antibody could improve performance in the Morris water maze (39). The gene discussed is TFRC; the disease is mucopolysaccharidosis type 2.